Literature DB >> 22731792

"Brittleness" in diabetes: easier spoken than broken.

Christina Voulgari1, Stamatina Pagoni, Spyridon Paximadas, Aaron I Vinik.   

Abstract

By definition, brittle diabetes (BD) is an unstable condition. Patients with BD suffer chronically from poor metabolic control, characterized by severe instability of glycemic values with frequent and unpredictable hypoglycemic and/or diabetic ketoacidosis episodes that cannot be attributed to failure in management. Quality of life is dramatically compromised because of very frequent acute complications leading to hospital admissions and because of premature chronic complications. It remains difficult to identify all patients with BD as diagnostic criteria are still not well defined. In practice, metabolic instability is manifested most obviously by chaotic glycemic profiles, which show greater and more unpredictable variation than in "stable" patients with diabetes. It is important that patients with BD are not adequately controlled, even by closely supervised, intensive insulin regimens, including continuous subcutaneous and/or intravenous insulin infusion. Their care is often very expensive in terms of time and resources, and their lives are constantly at risk for severe metabolic derangement. Management can also be frustrating and demoralizing for everyone involved, including the patient's family as well as the diabetes care team. Adopting a team approach, involving a broad range of disciplines, is essential in treating patients with BD and helping them to achieve and maintain both normoglycemia and quality of life.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22731792     DOI: 10.1089/dia.2012.0058

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  5 in total

1.  Outcomes of Pancreatic Islet Allotransplantation Using the Edmonton Protocol at the University of Chicago.

Authors:  Zehra Tekin; Marc R Garfinkel; W James Chon; Lindsay Schenck; Karolina Golab; Omid Savari; J Richard Thistlethwaite; Louis H Philipson; Colleen Majewski; Silvana Pannain; Sabarinathan Ramachandran; Kourosh Rezania; Seenu M Hariprasad; J Michael Millis; Piotr Witkowski
Journal:  Transplant Direct       Date:  2016-09-13

2.  Alexithymia in adults with brittle type 1 diabetes.

Authors:  Lorenzo Pelizza; Simona Pupo
Journal:  Acta Biomed       Date:  2019-05-23

3.  Analysis of factors associated with brittle response in patients with Parkinson's disease.

Authors:  Yayun Yan; Yanyan Li; Xiufeng Liu; Liyao Zhang; Lu Wang; Ying Chang
Journal:  Ann Clin Transl Neurol       Date:  2020-04-30       Impact factor: 4.511

4.  The "brittle response" to Parkinson's disease medications: characterization and response to deep brain stimulation.

Authors:  Daniel Martinez-Ramirez; Juan Giugni; Vinata Vedam-Mai; Aparna Wagle Shukla; Irene A Malaty; Nikolaus R McFarland; Ramon L Rodriguez; Kelly D Foote; Michael S Okun
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

Review 5.  A new look at brittle diabetes.

Authors:  Irl B Hirsch; Linda M Gaudiani
Journal:  J Diabetes Complications       Date:  2020-06-02       Impact factor: 2.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.